Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Radiotheranostics

Novel targets and radiopharmaceuticals in early phase clinical development for radiotheranostics: Focus on FAP, integrins, and beyond

Date

05 Mar 2025

Session

Radiotheranostics

Topics

Clinical Research;  Translational Research;  Nuclear Medicine and Clinical Molecular Imaging;  Targeted Therapy;  Immunotherapy;  Image-Guided Therapy

Tumour Site

Presenters

María De Miguel

Authors

M. De Miguel

Author affiliations

  • Early Phase Clinical Trial Unit, CIOCC - Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, 28050 - Madrid/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.